Selected research
Market Structure
Global Radioactive Iodine Ablation Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Radioactive Iodine Ablation Therapy market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Radioactive Iodine Ablation Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Radioactive Iodine Ablation Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Radioactive Iodine Ablation Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Radioactive Iodine Ablation Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Radioactive Iodine Ablation Therapy include Medtronic, HealthTronics, Galil Medical, AngioDynamics, Misonix, SonaCare Medical, Boston Scientific Corporation and Neuwave Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Radioactive Iodine Ablation Therapy market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Radioactive Iodine Ablation Therapy and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Radioactive Iodine Ablation Therapy sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radioactive Iodine Ablation Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.
Radioactive Iodine Ablation Therapy Segment by Company
Medtronic
HealthTronics
Galil Medical
AngioDynamics
Misonix
SonaCare Medical
Boston Scientific Corporation
Neuwave Medical
Radioactive Iodine Ablation Therapy Segment by Type
Gamma Radiation
Beta Radiation
Radioactive Iodine Ablation Therapy Segment by Application
Papillary Thyroid Cancer
Follicular Thyroid Cancer
Hurthle Cell Carcinoma
Other
Radioactive Iodine Ablation Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radioactive Iodine Ablation Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radioactive Iodine Ablation Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radioactive Iodine Ablation Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Radioactive Iodine Ablation Therapy market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioactive Iodine Ablation Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radioactive Iodine Ablation Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Radioactive Iodine Ablation Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Gamma Radiation
- Beta Radiation
Applications
- Papillary Thyroid Cancer
- Follicular Thyroid Cancer
- Hurthle Cell Carcinoma
- Other
Companies covered
- Medtronic
- HealthTronics
- Galil Medical
- AngioDynamics
- Misonix
- SonaCare Medical
- Boston Scientific Corporation
- Neuwave Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Radioactive Iodine Ablation Therapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Radioactive Iodine Ablation Therapy Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Radioactive Iodine Ablation Therapy Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Radioactive Iodine Ablation Therapy Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Radioactive Iodine Ablation Therapy Market Dynamics
- 2.1 Radioactive Iodine Ablation Therapy Industry Trends
- 2.2 Radioactive Iodine Ablation Therapy Industry Drivers
- 2.3 Radioactive Iodine Ablation Therapy Industry Opportunities and Challenges
- 2.4 Radioactive Iodine Ablation Therapy Industry Restraints
3 Radioactive Iodine Ablation Therapy Market by Manufacturers
- 3.1 Global Radioactive Iodine Ablation Therapy Revenue by Manufacturers (2021-2026)
- 3.2 Global Radioactive Iodine Ablation Therapy Sales by Manufacturers (2021-2026)
- 3.3 Global Radioactive Iodine Ablation Therapy Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Radioactive Iodine Ablation Therapy Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Radioactive Iodine Ablation Therapy Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Radioactive Iodine Ablation Therapy Manufacturers, Product Type & Application
- 3.7 Global Radioactive Iodine Ablation Therapy Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Radioactive Iodine Ablation Therapy Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Radioactive Iodine Ablation Therapy Players Market Share by Revenue in 2025
- 3.8.3 2025 Radioactive Iodine Ablation Therapy Tier 1, Tier 2, and Tier 3
4 Radioactive Iodine Ablation Therapy Market by Type
- 4.1 Radioactive Iodine Ablation Therapy Type Introduction
- 4.1.1 Gamma Radiation
- 4.1.2 Beta Radiation
- 4.2 Global Radioactive Iodine Ablation Therapy Sales by Type
- 4.2.1 Global Radioactive Iodine Ablation Therapy Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Radioactive Iodine Ablation Therapy Sales by Type (2021-2032)
- 4.2.3 Global Radioactive Iodine Ablation Therapy Sales Market Share by Type (2021-2032)
- 4.3 Global Radioactive Iodine Ablation Therapy Revenue by Type
- 4.3.1 Global Radioactive Iodine Ablation Therapy Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Radioactive Iodine Ablation Therapy Revenue by Type (2021-2032)
- 4.3.3 Global Radioactive Iodine Ablation Therapy Revenue Market Share by Type (2021-2032)
5 Radioactive Iodine Ablation Therapy Market by Application
- 5.1 Radioactive Iodine Ablation Therapy Application Introduction
- 5.1.1 Papillary Thyroid Cancer
- 5.1.2 Follicular Thyroid Cancer
- 5.1.3 Hurthle Cell Carcinoma
- 5.1.4 Other
- 5.2 Global Radioactive Iodine Ablation Therapy Sales by Application
- 5.2.1 Global Radioactive Iodine Ablation Therapy Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Radioactive Iodine Ablation Therapy Sales by Application (2021-2032)
- 5.2.3 Global Radioactive Iodine Ablation Therapy Sales Market Share by Application (2021-2032)
- 5.3 Global Radioactive Iodine Ablation Therapy Revenue by Application
- 5.3.1 Global Radioactive Iodine Ablation Therapy Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Radioactive Iodine Ablation Therapy Revenue by Application (2021-2032)
- 5.3.3 Global Radioactive Iodine Ablation Therapy Revenue Market Share by Application (2021-2032)
6 Global Radioactive Iodine Ablation Therapy Sales by Region
- 6.1 Global Radioactive Iodine Ablation Therapy Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Radioactive Iodine Ablation Therapy Sales by Region (2021-2032)
- 6.2.1 Global Radioactive Iodine Ablation Therapy Sales by Region (2021-2026)
- 6.2.2 Global Radioactive Iodine Ablation Therapy Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Radioactive Iodine Ablation Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Radioactive Iodine Ablation Therapy Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Radioactive Iodine Ablation Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Radioactive Iodine Ablation Therapy Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Radioactive Iodine Ablation Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Radioactive Iodine Ablation Therapy Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Radioactive Iodine Ablation Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Radioactive Iodine Ablation Therapy Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Radioactive Iodine Ablation Therapy Revenue by Region
- 7.1 Global Radioactive Iodine Ablation Therapy Revenue by Region
- 7.1.1 Global Radioactive Iodine Ablation Therapy Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Radioactive Iodine Ablation Therapy Revenue by Region (2021-2026)
- 7.1.3 Global Radioactive Iodine Ablation Therapy Revenue by Region (2027-2032)
- 7.1.4 Global Radioactive Iodine Ablation Therapy Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Radioactive Iodine Ablation Therapy Revenue (2021-2032)
- 7.2.2 North America Radioactive Iodine Ablation Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Radioactive Iodine Ablation Therapy Revenue (2021-2032)
- 7.3.2 Europe Radioactive Iodine Ablation Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Radioactive Iodine Ablation Therapy Revenue (2021-2032)
- 7.4.2 Asia-Pacific Radioactive Iodine Ablation Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Radioactive Iodine Ablation Therapy Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Radioactive Iodine Ablation Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Medtronic
- 8.1.1 Medtronic Company Information
- 8.1.2 Medtronic Business Overview
- 8.1.3 Medtronic Radioactive Iodine Ablation Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Medtronic Radioactive Iodine Ablation Therapy Product Portfolio
- 8.1.5 Medtronic Recent Developments
- 8.2 HealthTronics
- 8.2.1 HealthTronics Company Information
- 8.2.2 HealthTronics Business Overview
- 8.2.3 HealthTronics Radioactive Iodine Ablation Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 HealthTronics Radioactive Iodine Ablation Therapy Product Portfolio
- 8.2.5 HealthTronics Recent Developments
- 8.3 Galil Medical
- 8.3.1 Galil Medical Company Information
- 8.3.2 Galil Medical Business Overview
- 8.3.3 Galil Medical Radioactive Iodine Ablation Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Galil Medical Radioactive Iodine Ablation Therapy Product Portfolio
- 8.3.5 Galil Medical Recent Developments
- 8.4 AngioDynamics
- 8.4.1 AngioDynamics Company Information
- 8.4.2 AngioDynamics Business Overview
- 8.4.3 AngioDynamics Radioactive Iodine Ablation Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 AngioDynamics Radioactive Iodine Ablation Therapy Product Portfolio
- 8.4.5 AngioDynamics Recent Developments
- 8.5 Misonix
- 8.5.1 Misonix Company Information
- 8.5.2 Misonix Business Overview
- 8.5.3 Misonix Radioactive Iodine Ablation Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Misonix Radioactive Iodine Ablation Therapy Product Portfolio
- 8.5.5 Misonix Recent Developments
- 8.6 SonaCare Medical
- 8.6.1 SonaCare Medical Company Information
- 8.6.2 SonaCare Medical Business Overview
- 8.6.3 SonaCare Medical Radioactive Iodine Ablation Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 SonaCare Medical Radioactive Iodine Ablation Therapy Product Portfolio
- 8.6.5 SonaCare Medical Recent Developments
- 8.7 Boston Scientific Corporation
- 8.7.1 Boston Scientific Corporation Company Information
- 8.7.2 Boston Scientific Corporation Business Overview
- 8.7.3 Boston Scientific Corporation Radioactive Iodine Ablation Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Boston Scientific Corporation Radioactive Iodine Ablation Therapy Product Portfolio
- 8.7.5 Boston Scientific Corporation Recent Developments
- 8.8 Neuwave Medical
- 8.8.1 Neuwave Medical Company Information
- 8.8.2 Neuwave Medical Business Overview
- 8.8.3 Neuwave Medical Radioactive Iodine Ablation Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Neuwave Medical Radioactive Iodine Ablation Therapy Product Portfolio
- 8.8.5 Neuwave Medical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Radioactive Iodine Ablation Therapy Value Chain Analysis
- 9.1.1 Radioactive Iodine Ablation Therapy Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Radioactive Iodine Ablation Therapy Production Mode & Process
- 9.2 Radioactive Iodine Ablation Therapy Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Radioactive Iodine Ablation Therapy Distributors
- 9.2.3 Radioactive Iodine Ablation Therapy Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst